Skip to main content

Table 1 Participant characteristics

From: Monitoring training activity during gait-related balance exercise in individuals with Parkinson’s disease: a proof-of-concept-study

 

UPDRS motor part IIIa

 

Id

Sex

Age (yrs)

BMI

Duration of PD (yrs)

Tremor

Rigidity

Bradykinesia

Total

H&Y

Previous fallsb

No of falls

FOGc

Fear of fallingd

Gait speed (m/s)e

Physical activity (steps per day)f

1

F

66

17.4

5

4

7

20

41

2

Y

1

N

N

1.27

3656

2

M

72

23.5

1

2

13

21

32

2

N

N

N

0.80

2157

3

M

80

22.8

5

2

18

16

33

3

Y

12

N

Y

1.29

1343

4

M

65

27.1

1

3

6

21

50

2

N

N

N

1.53

8728

5

F

72

22.9

2

3

5

16

45

3

Y

1

N

Y

1.22

6593

6

F

83

23.5

2

9

7

14

48

3

N

N

Y

0.97

781

7

M

74

26.0

2

10

6

20

38

2

Y

6

N

N

1.16

1553

8

M

69

25.4

5

7

8

11

31

2

Y

3

Y

N

1.13

3258

9

M

63

21.9

6

8

15

20

47

2

Y

2

N

N

1.40

7558

10

M

70

26.0

7

8

12

19

39

2

N

N

Y

1.13

10696

Mean

71

23.8

3

6

10

18

40

1.19

4632

  1. Abbreviations: BMI Body Mass Index; PD Parkinson’s disease; UPDRS Unified Parkinson’s Disease Rating Scale; H&Y Hoehn and Yahr, FOG freezing of gait
  2. aMaximum total score is 108 points (higher score = higher severity of motor symptoms). Sub-scores were calculated as follows: tremor; sum of item 20–21, rigidity; sum of item 22, and bradykinesia; sum of item 23–26 and item 31
  3. bFalls assessed retrospectively the previous 12 months and defined as an unexpected event in which the participants came to rest on the ground, floor, or lower level
  4. cFreezing of gait assessed by item 14 of UPDRS activities of daily living part II (a score ≥2 indicated freezing of gait)
  5. dFear of falling assessed with a single-item question (“In general, are you afraid of falling?”)
  6. eSelf-selected gait speed assessed with an electronic walkway system (GAITRite® system, CIR Systems, Inc., Haverton, PA, USA)
  7. fPhysical activity level assessed by accelerometry (Actigraph GT3X+) in free-living conditions during 4 – 7 consecutive days